Skip to Content

Methyltestosterone Pregnancy and Breastfeeding Warnings

Methyltestosterone is also known as: Android, Android-10, Android-25, Methitest, Oreton Methyl, Testred, Virilon

Methyltestosterone Pregnancy Warnings

Methyltestosterone has been assigned to pregnancy category X by the FDA. Androgen use, particularly during the first trimester of pregnancy, causes virilization of the external genitalia of the female fetus. Reversible oligospermia may occur after prolonged androgen administration or excessive dosage. There are no controlled data in human pregnancy. Methyltestosterone use is considered contraindicated during pregnancy.

If reversible oligospermia occurs, the androgen can be discontinued and if restarted, a lower dosage should be utilized.

See references

Methyltestosterone Breastfeeding Warnings

There are no data on the excretion of methyltestosterone into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Android Capsules (methyltestosterone)." ICN Pharmaceuticals Inc, Costa Mesa, CA.

References for breastfeeding information

  1. "Product Information. Android Capsules (methyltestosterone)." ICN Pharmaceuticals Inc, Costa Mesa, CA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.